Steven Cohen’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67.7K Sell
18,012
-39,117
-68% -$165K ﹤0.01% 3717
2026
Q2
$262K Buy
57,129
+29,103
+104% +$121K ﹤0.01% 3421
2026
Q1
$96.7K Buy
+28,026
New +$87.7K ﹤0.01% 3616
2023
Q2
– Sell
-86
Closed -$623 – 2884
2023
Q1
$623 Sell
86
-65,980
-100% -$705K ﹤0.01% 2134
2022
Q4
$848K Sell
66,066
-501,063
-88% -$6.54M ﹤0.01% 1078
2022
Q3
$8.01M Buy
567,129
+25,085
+5% +$330K 0.03% 575
2022
Q2
$6.68M Buy
542,044
+330,513
+156% +$4.91M 0.03% 623
2022
Q1
$3.59M Buy
+211,531
New +$4.05M 0.01% 770
2021
Q1
– Sell
-16,667
Closed -$245K – 1216
2020
Q4
$245K Buy
+16,667
New +$356K ﹤0.01% 865

Other funds holding WHWK

Steven Cohen's WHWK Position: Q3 2026 in Review

Steven Cohen reduced its Whitehawk Therapeutics (WHWK) stake by 68% in Q3 2026, selling an estimated $165K and leaving 18,012 shares worth $67.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3717.

Steven Cohen first reported a position in WHWK in Q4 2020 and has held it in 9 quarters since. The position peaked at $8.01M in Q3 2022. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.

  • Steven Cohen held 18,012 shares of Whitehawk Therapeutics worth $67.7K as of Q3 2026.
  • Steven Cohen sold 39,117 Whitehawk Therapeutics shares in Q3 2026, an estimated $165K.
  • Whitehawk Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3717 holding.
  • Steven Cohen first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 9 quarters since.
  • Steven Cohen's Whitehawk Therapeutics position peaked at $8.01M in Q3 2022.
  • 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.